Chester County News and Community Website
CONSHOHOCKEN, PA — Cencora, Inc. (NYSE: COR) announced it will release its financial results for the fourth quarter of fiscal 2025 on Wednesday, November 5, 2025, before the opening of …
Cencora to Announce Fourth Quarter Fiscal 2025 Results on November 5 Read More CONSHOHOCKEN, PA — Cencora, Inc. (NYSE: COR) announced its Board of Directors has appointed D. Mark Durcan as Chairman, effective October 1, 2025. Durcan, currently the company’s Lead Independent Director, …
Cencora Names D. Mark Durcan Chairman of the Board Read More CONSHOHOCKEN, PA — Cencora, Inc. (NYSE: COR) posted higher revenue and profits in its fiscal third quarter, driven by growth in both U.S. and international healthcare operations, and raised its full-year …
Cencora Lifts Earnings Outlook After Strong Q3 Performance Read More CONSHOHOCKEN, PA — Good Neighbor Pharmacy, a network of independent pharmacies supported by Cencora, gathered more than 4,000 pharmacy owners, partners, and industry experts at the MGM Grand in Las Vegas …
Good Neighbor Pharmacy Showcases Independent Pharmacy Excellence at 2025 ThoughtSpot Conference Read More CONSHOHOCKEN, PA — Cencora, Inc. (NYSE: COR) has elected Lori J. Ryerkerk as an independent director to its Board of Directors, effective June 1, 2025. The addition of Ryerkerk brings …
Cencora Welcomes Lori J. Ryerkerk to Board of Directors Read More CONSHOHOCKEN, PA — Cencora, Inc. (NYSE: COR) announced robust fiscal second-quarter results for 2025, reporting a 10.3% year-over-year increase in revenue, reaching $75.5 billion. The company also posted notable earnings …
Cencora Reports Strong Q2 2025 Results, Raises Outlook Read More CONSHOHOCKEN, PA — Cencora, Inc. (NYSE: COR) has announced an agreement to repurchase approximately $50 million worth of its common stock from Walgreens Boots Alliance Holdings LLC. The transaction aligns with …
Cencora Announces $50 Million Share Repurchase from Walgreens Boots Alliance Read More CONSHOHOCKEN, PA — Cencora has significantly amplified its efforts to combat drug shortages through the expansion of its sure supply program, a forward-thinking initiative that now includes nearly 200 critical medications—an …
Cencora Expands Sure Supply Program to Combat Drug Shortages Read More CONSHOHOCKEN, PA — Cencora, Inc. (NYSE: COR) has reported robust financial results for the first quarter of fiscal year 2025, posting a 12.8% year-over-year revenue increase to $81.5 billion. Adjusted diluted …
Cencora Reports Strong Q1 Results, Raises 2025 Guidance Read More